TransEnterix Inc. [AMEX: TRXC] gained 11.60% on the last trading session, reaching $3.56 price per share at the time. The company report on February 2, 2021 that TransEnterix Announces Closing of $79.6 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares.
Proceeds from offering, in combination with recent financing activity, extends cash runway into 2024.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced the closing of its previously announced underwritten public offering of its common stock. Including the full exercise of the underwriter’s option to purchase additional shares, the Company issued 26,545,832 shares at a public offering price of $3.00 per share. The aggregate gross proceeds from this offering is approximately $79.64 million, before deducting underwriting discounts and commissions and offering expenses.
TransEnterix Inc. represents 176.00 million in outstanding shares, while the company has a total market value of $444.39 million with the latest information. TRXC stock price has been found in the range of $3.10 to $3.60.
If compared to the average trading volume of 23.75M shares, TRXC reached a trading volume of 20002518 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about TransEnterix Inc. [TRXC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TRXC shares is $1.45 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TRXC stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for TransEnterix Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 20, 2021. While these analysts kept the previous recommendation, RBC Capital Mkts dropped their target price from $3 to $1. The new note on the price target was released on August 08, 2019, representing the official price target for TransEnterix Inc. stock. Previously, the target price had yet another raise to $1.60, while Piper Jaffray analysts kept a Neutral rating on TRXC stock.
The Average True Range (ATR) for TransEnterix Inc. is set at 0.51, with the Price to Sales ratio for TRXC stock in the period of the last 12 months amounting to 158.71. The Price to Book ratio for the last quarter was 5.56.
Trading performance analysis for TRXC stock
TransEnterix Inc. [TRXC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 20.27. With this latest performance, TRXC shares gained by 270.83% in over the last four-week period, additionally plugging by 677.97% over the last 6 months – not to mention a rise of 180.31% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TRXC stock in for the last two-week period is set at 68.57, with the RSI for the last a single of trading hit 66.90, and the three-weeks RSI is set at 69.63 for TransEnterix Inc. [TRXC]. The present Moving Average for the last 50 days of trading for this stock 1.51, while it was recorded at 3.36 for the last single week of trading, and 0.70 for the last 200 days.
TransEnterix Inc. [TRXC]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and TransEnterix Inc. [TRXC] shares currently have an operating margin of -1075.38 and a Gross Margin at -263.76. TransEnterix Inc.’s Net Margin is presently recorded at -1807.54.
Return on Total Capital for TRXC is now -71.81, given the latest momentum, and Return on Invested Capital for the company is -121.23. Return on Equity for this stock declined to -137.65, with Return on Assets sitting at -95.03. When it comes to the capital structure of this company, TransEnterix Inc. [TRXC] has a Total Debt to Total Equity ratio set at 4.52. Additionally, TRXC Total Debt to Total Capital is recorded at 4.33, with Total Debt to Total Assets ending up at 3.12. Long-Term Debt to Equity for the company is recorded at 2.52, with the Long-Term Debt to Total Capital now at 2.41.
Reflecting on the efficiency of the workforce at the company, TransEnterix Inc. [TRXC] managed to generate an average of -$946,018 per employee. Receivables Turnover for the company is 1.43 with a Total Asset Turnover recorded at a value of 0.05.TransEnterix Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.30 and a Current Ratio set at 3.20.
TransEnterix Inc. [TRXC]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, TransEnterix Inc. posted -0.83/share EPS, while the average EPS was predicted by analysts to be reported at -0.62/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -33.90%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TRXC.
An analysis of insider ownership at TransEnterix Inc. [TRXC]
There are presently around $29 million, or 21.70% of TRXC stock, in the hands of institutional investors. The top three institutional holders of TRXC stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 1,932,458, which is approximately 506.8% of the company’s market cap and around 0.20% of the total institutional ownership; VANGUARD GROUP INC, holding 1,825,704 shares of the stock with an approximate value of $6.5 million in TRXC stocks shares; and MASTERS CAPITAL MANAGEMENT LLC, currently with $3.2 million in TRXC stock with ownership of nearly 0% of the company’s market capitalization.
Positions in TransEnterix Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 22 institutional holders increased their position in TransEnterix Inc. [AMEX:TRXC] by around 3,959,268 shares. Additionally, 35 investors decreased positions by around 1,606,580 shares, while 31 investors held positions by with 2,536,154 shares. The mentioned changes placed institutional holdings at 8,102,002 shares, according to the latest SEC report filing. TRXC stock had 12 new institutional investments in for a total of 915,909 shares, while 21 institutional investors sold positions of 1,128,911 shares during the same period.